Literature Review

Ohio payer beats UnitedHealthcare in racketeering lawsuit, awarded $50M Becker's Payer Issues; by Jakob Emerson; 3/19/25 An Ohio jury awarded Medical Mutual of Ohio over $50 million in damages on March 12 after the payer prevailed in its lawsuit against FrontPath Health Coalition and HealthScope Benefits, a subsidiary of UnitedHealthcare. FrontPath offers employee benefits solutions, and HealthScope is a third-party administrator. .. The defendants were found to have committed federal wire fraud, telecommunications fraud, tampered with records, and obstructed justice by submitting false bid information. The jury found that the conspiracy resulted in significant damages to Medical Mutual and ultimately caused taxpayers to pay higher healthcare costs than necessary.

Executive Personnel Changes - 3/14/25

UnitedHealth Group's year of DOJ probes, layoffs and backlash Modern Healthcare; by Lauren Berryman; 2/24/25 UnitedHealth Group has faced an unprecedented past year, navigating events that have tested its finances, operations and reputation. Here is a timeline of key events during the company’s past 12 months. [Click here and scroll down to the timeline with links to Modern Healthcare's articles through the year.]

Humana posts $693M loss in Q4 Becker's Payer Issues; by Jakob Emerson; 2/11/25 Humana lost $693 million in the fourth quarter of 2024, according to the company's year-end earnings report published Feb. 11. The results reflect increased benefits expenses, particularly in Medicare Advantage and state-based contracts. Despite the challenges, the company projected earnings per share of $15.88 for 2025, with an adjusted EPS of approximately $16.25. Total revenues in the fourth quarter were $29.2 billion, up 10.4% year over year. In 2024, total revenues were $117.8 billion, up 10.7%. Humana posted a net loss of $693 million in the fourth quarter, compared to a $541 million net loss the year prior. In 2024, the company's net income totaled nearly $1.2 billion, down 52%.

Executive Personnel Changes - 1/31/25

Executive Personnel Changes - 1/24/25

Executive Personnel Changes - 1/17/25

Executive Personnel Changes - 12/27/24

Executive Personnel Changes - 12/13/24 

Executive Personnel Changes - 11/22/24 

Amedisys is now oversold (AMED) Nasdaq; by BNK Invest; 10/31/24 Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30. In trading on Thursday [10/31], shares of Amedisys, Inc. (Symbol: AMED) entered into oversold territory, hitting an RSI reading of 29.4, after changing hands as low as $94.76 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 44.0. ...

Executive Personnel Changes - 10/25/24